A process for oligomerizing isobutene comprises contacting a feedstock comprising isobutene with a catalyst comprising a MCM-22 family molecular sieve under conditions effective to oligomerize the isobutene, wherein said conditions including a temperature from about 45° C. to less than 140° C. The isobutene may be a component of a hydrocarbon feedstock containing at least one additional C4 alkene. In certain aspects, isobutene oligomers are separated from a first effluent of the oligomerization to produce a second effluent comprising at least one n-butene. The second effluent can be contacted with an alkylation catalyst to produce sec-butylbenzene.

This invention relates to the oligomerization of olefinic compounds in the presence of an activated oligomerization catalyst. The invention also extends to a particular manner for providing an activated oligomerization catalyst. According to the present invention, there is provided a process for producing an oligomeric product by the oligomerization of at least one olefinic compound, the process including (a) providing an activated oligomerization catalyst by combining, in any order, iii) a source of chromium, ιv) a ligating compound of the formula (R1)mX1(Y)X2(R2)n wherein X1 and X2 are independently an atom selected from the group consisting of nitrogen, phosphorus, arsenic, antimony, bismuth, oxygen, sulphur and selenium or said atom oxidized by S, Se, N or O where the valence of X1 and/or X2 allows for such oxidation, Y is a linking group between X1 and X2 which linking group contains at least one nitrogen atom which is directly bonded to X1 or X2, m and n are independently 0, 1 or a larger integer, and R1 and R2 are independently hydrogen, a hydrocarbyl group, an organoheteryl group or a heterohydrocarbyl group, and the respective R1 groups are the same or different when m>1, and the respective R2 groups are the same or different when n>1, in) a catalyst activator which is an organoboron compound including a cation and a non-coordinating anion of the general formula [(R10)xL*-H]+[B(R20)4]− wherein L* is an atom selected from the group consisting of N, S and P, the cation [(R10)x L*-H]* is a Bronsted acid, x is an integer 1, 2 or 3, each R10 is the same or different when x is 2 or 3 and each is a —H, hydrocarbyl group or a heterohydrocarbyl group, provided that at least one of R10 comprises at least 6 carbon atoms and provided further that the total number of carbon atoms in (R10)x collectively is greater than 12, R20 independently at each occurrence is selected from the group consisting of hydride, dialkylamido, halide, alkoxide, aryloxide, hydrocarbyl, halosubstituted-hydrocarbyl radicals, halosubstituted-alkoxide, halosubstituted-aryloxide and a halosubstituted aromatic ring moiety with at least one halide substituent on the aromatic ring, and vi) an aliphatic solvent, and (b) contacting the at least one olefinic compound with the activated oligomerization catalyst to produce an oligomeric product.

A particle-polymer hybrid material can include: a substance having the structure of Formula 1 Z(Y-FP)m, wherein Z is a particle smaller than 1 mm; m is an integer; Y is a linker including a silicon atom linked to the particle; FP is a functionalized polymer having: a first structure derived from a first norbornene compound linked to the Y; and one or more repeating units linked to the first structure, each unit being derived from a second norbornene compound and having a functional group.

The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in the liver. The present invention employs low molecular weight cationic lipids with one short lipid chain to enhance the efficiency and tolerability of in vivo delivery of siRNA.

Disclosed are soft, high refractive index, acrylic device materials. The materials contain a copolymeric additive for glistening resistance.

A method of preparing a simple ceramic ingot of a spent filter having radioactive cesium trapped therein, and a ceramic ingot of a spent filter having improved properties such as leach resistance, thermal stability, and cesium content are provided. The method includes grinding and mixing a spent filter having cesium trapped therein, adding a solidifying agent, and sintering the spent filter. The method of preparing a ceramic ingot of a spent filter can be useful in preparing the ceramic ingot of the spent filter from only the spent filter by means of simple grinding and sintering, and in preparing the ceramic ingot of the spent filter by adding a small amount of a solidifying agent. The ceramic ingot of the spent filter has a high density and improved thermal stability, and shows improved leach resistance since a leach rate of a radioactive material is remarkably low. Therefore, the spent filter having radioactive cesium trapped therein can be effectively used to prepare a stable ceramic ingot.

In this application, a set of orthogonal functions is introduced whose power spectral densities are all rectangular shape. To find the orthogonal function set, it was considered that their spectrums (Fourier transforms of the functions) are either real-valued or imaginary-valued, which are corresponding to even and odd real-valued time domain signals, respectively. The time domain functions are all considered real-valued because they are actually physical signals. The shape of the power spectral densities of the signals are rectangular thus, the Haar orthogonal function set can be employed in the frequency domain to decompose them to several orthogonal functions. Based on the inverse Fourier transform of the Haar orthogonal functions, the time domain functions with rectangular power spectral densities can be determined. This is equivalent to finding the time-domain functions by taking the inverse Fourier transform of the frequency domain Walsh functions. The obtained functions are sampled and truncated to generate finite-length discrete signals. Truncation destroys the orthogonality of the signals. The Singular Value Decomposition method is used to restore the orthogonality of the truncated discrete signals.

A Montgomery inverse calculation device includes a plurality of registers each storing a value of a variable, a modulus register storing a modulus, a multiplier performing multiplication on the modulus. A comparator compares the value of the variable stored in each of the registers with an output value of the multiplier and generates a plurality of control signals. A plurality of shifters shifts bits of a value of a variable stored in a corresponding register among the registers in response to at least one first control signal, and a quotient generation block calculates a quotient of mod 2m with respect to values output from some of the shifters in response to a second control signal. A calculation block calculates an updated value of an output value of each of the shifters using the quotient in response to at least one third control signal.

Described is a radiation-crosslinkable hotmelt adhesive comprising at least one radiation-crosslinkable poly(meth)acrylate formed to an extent of at least 60% by weight of C1 to C10 alkyl(meth)acrylates and at least one oligo(meth)acrylate which comprises nonacrylic C C double bonds and has a K value of less than or equal to 20. The hotmelt adhesive comprises a photoinitiator which may be present in the form of an additive not attached to the poly(meth)acrylate and/or not attached to the oligo(meth)acrylate, may be incorporated by copolymerization into the poly(meth)acrylate, and/or may be attached to the oligo(meth)acrylate. The hotmelt adhesive can be used for producing adhesive tapes.

A method of automating the deployment of a number of enterprise applications on one or more computer data processing systems. Each enterprise application or update is stored in a dynamic distribution directory and is provided with identifying indicia, such as stage information, target information, and settings information. When automated enterprise deployment is invoked, computer instructions in a computer readable medium provide for initializing deployment, performing deployment, and finalizing deployment of the enterprise applications or updates.

The present invention relates to a method for preparing menthone, starting from isopulegol, using specific homogeneous catalysts.

A method of adjusting a speed of a mobile machine is provided. Image data of a location is collected where currently generated sensor data and previously generated sensor data indicate a discontinuity in sensor data. The image data is analyzed to determine if a non-motion blur score for the image data is above a threshold value. Then, a speed of the mobile machine is adjusted based on a determination that the non-motion blur score is above the threshold value.

An electronic device for text prediction in a virtual keyboard. The device includes a memory including an input determination module for execution by the microprocessor, the input determination module being configured to: receive signals representing input at the virtual keyboard, the virtual keyboard being divided into a plurality of subregions, the plurality of subregions including at least one subregion being associated with two or more characters and/or symbols of the virtual keyboard; identify a subregion on the virtual keyboard corresponding to the input; determine any character or symbol associated with the identified subregion; and if there is at least one determined character or symbol, provide the at least one determined character or symbol to a text prediction algorithm.

The invention relates to (among other things) oligomer-foscarnet conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered un-conjugated foscarnet compounds.

A wind direction indicating and time display unit is provided for use at the tee areas of a golf course. The unit wind direction indicating device is mounted on an upper surface of a support structure and extends upwardly therefrom. The wind direction indicating device includes a support pole, a sleeve mounted for rotation on the pole at the top thereof, a wind direction indicating element, such as a flag, secured to the sleeve and movable in response to changes in wind direction, and a pole support fitting. Secured to the upper surface of the support structure. A time display device, such as a clock, is secured in a laterally facing wall surface of the support structure.

An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 202.

This invention relates to a process for preparing an oligonucleotide 5'-triphosphate. The process comprises the steps of: (a) synthesizing an oligonucleotide having a 5' hydroxyl moiety; (b) reacting the 5' hydroxyl moiety with a reagent of formula I: to convert the 5' hydroxyl moiety to a 5'-H-phosphonate, wherein R1 and R2 are each independently selected from the group consisting of haloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocycle, and substituted heterocycle, acyl, phosphoryl, substituted alkyl acyl, substituted heteroalkyl acyl, substituted aryl acyl or substituted heteroaryl acyl, substituted alkyl phosphoryl, substituted heteroalkyl acyl, substituted aryl phosphoryl, and substituted heteroaryl phosphoryl; (c) activating the H-phosphonate of step (b) by reacting the H-phosphonate with a silylating agent, a halogenated oxidizing agent, a nitrogen-containing heteroaryl, or a combination thereof, to form an activated H-phosphonate; and (d) treating the oligonucleotide having an activated H-phosphonate from step (c) with a poly(alkylammonium)pyrophosphate.

A recombinant micro-organism producing resveratrol by a pathway in which phenylalanine ammonia lyase (PAL) produces trans-cinnamic acid from phenylalanine, cinnamate 4-hydroxylase (C4H) produces 4-coumaric acid from said trans-cinnamic acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA, or in which L-phenylalanine- or tyrosine-ammonia lyase (PAL/TAL) produces 4-coumaric acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA. The micro-organism may be a yeast, fungus or bacterium including Saccharomyces cerevisiae, E. coli, Lactococcus lactis, Aspergillus niger, or Aspergillus oryzae.

The present invention relates to oligomer compounds (oligomers) for the treatment and prevention of acute myeloid leukemia, which target GLI2 mRNA in a cell, leading to reduced expression of GLI2.

The present disclosure provides reagents that can be used to label synthetic oligonucleotides with rhodamine dyes or dye networks that contain rhodamine dyes.

A region growing algorithm for controlling leakage is presented including a processor configured to select a starting point for segmentation of data, initiate a propagation process by designating adjacent voxels around the starting point, determine whether any new voxels are segmented, count and analyze the segmented new voxels to determine leakage levels, and identify and record segmented new voxels from a previous iteration when the leakage levels exceed a predetermined threshold. The processor is further configured to perform labeling of the segmented new voxels of the previous iteration, select the segmented new voxels from the previous iteration when the leakage levels fall below the predetermined threshold, and create a voxel list based on acceptable segmented voxels found in the previous iteration.

The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in the liver. The present invention employs low molecular weight cationic lipids comprising at least one short lipid chain to enhance the efficiency and tolerability of in vivo delivery of siRNA.

Compounds and methods related to the activation of the TrkB receptor are provided. The methods include administering a 7,8-dihydroxyflavone derivative with modified flavone or heterocyclic ring to a subject in need thereof. Methods and compounds for the treatment of disorders including neurologic disorders, neuropsychiatric disorders, and metabolic disorders (e.g., obesity) are provided.

The present invention relates to new salts of 6-(propyl-(2-thiophen-2-ylethyl)amino)tetralin-1-ol(rotigotine), their use as a medicament, for example for the treatment of CNS disorders like Parkinson Disease, RLS, fibromyalgia and/or depression, in particular through electromotive administration. The present invention relates to pharmaceutical formulations suitable for iontophoresis that provide enhanced iontophoretic delivery of rotigotine to at least one target tissue. The formulations are further characterized by good to excellent solubility of the salts in aqueous solutions.

The disclosure provides compounds and methods of using Apogossypolone derivatives for treating diseases and disorders. In particular, the disclosure provides compounds of Formula I: or a pharmaceutically acceptable salt, hydrate, or solvate thereof, and provides methods for the preparation of compounds of Formula I; and methods for treating cancer, autoimmune diseases, and inflammation by administering a compound of Formula I.

The invention relates to 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives of formula I with progesterone-antagonizing action and methods of production thereof, use thereof for the treatment and/or prevention of diseases and use thereof for producing medicinal products for the treatment and/or prevention of diseases, in particular uterine fibroids (myomata, uterine leiomyomata), endometriosis, heavy menstrual bleeding, meningiomata, hormone-dependent breast cancers and menopause-associated complaints or for fertility control and emergency contraception.

The invention relates to compounds of formula (I): wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.

The present invention provides a compound which functions as a selective vitamin D receptor modulator and has action-selectivity or tissue-selectivity such that it does not induce hypercalcemia but causes other effects. There is provided a compound represented by formula (I), a solvate thereof or a prodrug thereof. wherein m and n each independently represent 1 or 0;R represents a hydrogen atom or an alkyl group;Y represents an ethane-1,1-diyl group or an ethyne-1,2-diyl group; andZ1 represents a hydrogen atom and Z2 represents a hydroxyalkoxy group, orZ1 and Z2 jointly form a methylene group.

A method is disclosed for curing ink printed images on golf balls by printing an image onto a golf ball and exposing the printed image to infrared radiation, then exposing the printed image to ultraviolet radiation.

Methods and devices for determining optimal Atrial to Ventricular (AV) pacing intervals and Ventricular to Ventricular (VV) delay intervals in order to optimize cardiac output. Impedance, preferably sub-threshold impedance, is measured across the heart at selected cardiac cycle times as a measure of chamber expansion or contraction. One embodiment measures impedance over a long AV interval to obtain the minimum impedance, indicative of maximum ventricular expansion, in order to set the AV interval. Another embodiment measures impedance change over a cycle and varies the AV pace interval in a binary search to converge on the AV interval causing maximum impedance change indicative of maximum ventricular output. Another method varies the right ventricle to left ventricle (VV) interval to converge on an impedance maximum indicative of minimum cardiac volume at end systole. Another embodiment varies the VV interval to maximize impedance change.

A method is disclosed for preparing a soft tissue site, and augmenting the soft tissue site, such as the breast(s), scar, depression, or other defect, of a subject through use of devices that exert a distractive force on the breast(s) and grafting of autologous fat tissue such as domes with sealing rims for surrounding each of the soft tissue site and a regulated pump. The method for preparing the soft tissue site, and enhancing fat graft results, entails application of the distracting force to the targeted soft tissue site at least intermittently for some period of time and preferably several weeks prior to the graft procedure. A related aspect of the invention includes following the preparation steps by transfer of fat from other areas of the subject to the subject's soft tissue site, and then reapplication of the distractive force to the soft tissue site that received the autologous fat graft. Alternatively, fat from genetically related sources may be used, and the fat may be further processed prior to injection. Substantial soft tissue augmentation, high rates of graft survival and negligible graft necrosis (data demonstrating 80% survival and only 20% necrosis is presented) or calcification result from the practice of these methods.

The present invention relates to the use of selective adenosine A1 agonists, in particular the dicyanopyridines of formula (I), for the treatment and/or prophylaxis of glaucoma and ocular hypertension as well as the their use for the production of a medicament for the treatment and/or prophylaxis of glaucoma and ocular hypertension.

The disclosure relates to BAX activators and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a compound disclosed herein or pharmaceutically acceptable salt to a subject in need thereof.

The present invention relates to a diesel oxidation catalyst comprising a carrier substrate, and a first washcoat layer disposed on the substrate, the first washcoat layer comprising palladium supported on a support material comprising a metal oxide, gold supported on a support material comprising a metal oxide, and a ceria comprising compound, as well as a process for the preparation of such catalyst.

Disclosed herein is a GO-Gd-DTPA (gadolinium-diethylenetriamine pentaacetic-graphene oxide) complex, which is formed by an ester bond of graphene oxide (GO) and gadopentetic acid (Gd-DTPA). Since the GO-Gd-DTPA can stably exist in the body because it has high stability in water, it is expected that it can be effectively used as an MRI contrast agent.

Provided is an oligonucleotide containing an azobenzene derivative, represented by Formula (1) or (2) below: (in the formulae, A1 and A2 each independently represent a hydrogen atom, nucleotide or oligonucleotide, B1 and B2 each independently represent a hydroxyl group, nucleotide or oligonucleotide, R11 and R12 each independently represent a C1-20 alkyl group, R21 and R22 each independently represent a hydrogen atom or C1-20 alkyl group, and R13 to R18 and R23 to R28 each independently represent a hydrogen atom; a C1-20 alkyl group or alkoxy group optionally substituted with a halogen atom, hydroxyl group, amino group, nitro group or carboxyl group; a C2-20 alkenyl group or alkynyl group optionally substituted with a halogen atom, hydroxyl group, amino group, nitro group or carboxyl group; a hydroxyl group; a halogen atom; an amino group; a nitro group; or a carboxyl group).

Cyclic CRF antagonist peptides having improved properties of “drugability”. The peptides are 33 residues in length with a lactam bond between the residues in position 22 and 25; however, they may be N-terminally shortened by up to 3 residues.

To provide a diagnostic and therapeutic medicament, a bombesin analog peptide antagonist conjugate is provided which has general Formula (I), wherein A is a metal chelator comprising at least one radionuclide metal, B is a spacer linked to N-terminal of C or a covalent bond and C is a bombesin analog peptide antagonist having a sequence as claimed, where further x is an integer from 1 to 3 and n is an integer from 1 to 6. [A-(B)n]x—C (I)

The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilizate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Whether the growth hormone (GH)/Insulin-like growth factor 1(IGF-I) axis exerts cardioprotective effects remains controversial; and the underlying mechanism(s) for such actions are unclear. Here we tested the hypothesis that growth-hormone releasing hormone (GHRH) directly activates cellular reparative mechanisms within the injured heart, in a GH/IGF-I independent fashion. Following experimental myocardial infarction (MI), rats were randomly assigned to receive, during a 4 week period, either placebo (n=14), rat recombinant GH (rrGH, n=8) or JI-38 (n=8; 50 μg/Kg/day), a potent GHRH-agonist. JI-38 did not elevate serum levels of GH or IGF-I, but markedly attenuated the degree of cardiac functional decline and remodeling after injury. In contrast, GH administration markedly elevated body weight, heart weight, circulating GH and IGF-I, but did not offset the decline in cardiac structure and function. Whereas, both JI-38 and GH augmented levels of cardiac precursor cell proliferation, only JI-38 increased anti-apoptotic gene expression. The receptor for GHRH was detectable on myocytes supporting direct activation of cardiac signal transduction. Collectively, these findings demonstrate that within the heart GHRH-agonists can activate cardiac repair following MI, suggesting the existence of a potential signaling pathway based on GHRH in the heart. The phenotypic profile of the response to a potent GHRH agonist has therapeutic implications.

A golf tee insertion depth measurement tool provides a gauge to facilitate marking the shaft of a golf tee to indicate a desired insertion depth that provides an optimum height for a golf ball placed on the tee, which ball is to be struck by a club face having a height H. The tool has a base portion and an elongate stem portion having a stem length. The base portion has a first surface and a second surface. The stem portion is connected to the base portion and extends outwardly away from the second surface of the base portion. The stem portion is first marked along its length at a location corresponding to the club face height H above the ground. The shaft of a tee is then marked at a location corresponding to the marked location on the stem portion to provide the correct insertion depth for the tee.

A 2-D scanning system uses a fast-rotating raster-polygon as a single scanning component to produce straight scan lines over a 2-D image surface. An approach angle of incident light beams to the raster-polygon is selected to minimize pin-cushion distortion of scan lines introduced by polygon scanning on the image surface, and a tilt angle of the rotational axis of the raster-polygon is selected to position said polygon-scanning distortion symmetrically on the image surface. In addition, scan optics are configured to generate a predetermined amount of barrel distortion of scan lines on the image surface to compensate for pin-cushion distortion introduced by polygon scanning.

An improved rearward-hinged and forward-hinged, rotatable and tiltable receiving table for a agricultural bale transport vehicle that selectively tilts and rotates a layer of bales resting thereupon 90 degrees relative to a preceding bale layer on the transport vehicle to criss-cross tie a load of bales (a plurality of layers of bales) together in a load stack offloaded from the transport vehicle to the field for later pickup and movement or deposit in a bale storage area. Preferably, the bale transport vehicle is a mid-size or big bale stack wagon having a Mil-Stak® bale loader previously installed or concurrently being installed. The invention enables the lifting, tilting, rotating, and depositing of one mid-size or big bale or a plurality of mid-size or big bales from a rearward-hinged and forward-hinged bale receiving table of the bale transport vehicle onto a rear-hinged stack load table for consolation into a load with other layers of bales for transport from the field. The invention allows selective 90 degree rotation of a layer of bales relative to a preceding layer of bales of the bale stack on the rear-hinged stack load table.

An apparatus for loading and unloading a truck with cargo includes a mounting frame for attaching adjacent to a truck doorway. The mounting frame includes a first guide member forming a first channel, a first support member slideably received within the first channel, a second guide member forming a second channel, and a second support member slideably received within the second channel. A platform for supporting the cargo is pivotally coupled to the first support member and to the second support member. A power driven lift elevator slides the first support member within the first channel and slides the second support member within the second channel to thereby raise and lower the platform. A power driven platform elevator pivots the platform respect to the first and second support members to move the platform between horizontal and vertical positions.

The present invention relates to a process of synthesis of α-sialyl oligosaccharides and in particular of 6'-sialyllactose and its salts comprising a step of coupling by Koenigs-Knorr reaction under conditions that allow its use on an industrial scale.

An output thin film transistor threshold voltage offset compensation circuit, a GOA circuit, and a display. The circuit includes: a first capacitor, comprising a first electrode and a second electrode, the first electrode being connected to the gate of an output thin film transistor and receiving a charge signal, the second electrode being connected to the drain of the output thin film transistor, the first capacitor being used for, under the action of the charge signal, making the first electrode and the second electrode have a same voltage, so that a voltage difference between the drain and the source of the output thin film transistor is equal to a threshold voltage thereof; a first switch unit, connected to the drain and the source of the output thin film transistor, and opening under the action of a first clock signal, so that a voltage difference between the gate and the source of the output thin film transistor is equal to the threshold voltage thereof.

A bilateral cargo strap system is provided as a means of securing a variety of different cargo within a storage area. The bilateral cargo strap system utilizes a combination of elastic straps with perpendicularly positioned stabilizing rods to improve retention of a variety of cargo within a storage area. The elastic straps extend over the retained cargo and are used as the means of engaging mounting features within the storage area. The stabilizing rods effectively distribute the tension force of the elastic straps over the retained cargo securing it in place within the storage space. The bilateral cargo strap system is versatile and may be used to secure a wide variety of cargo including, but not limited to, kayaks, coolers, bicycles, lumber, and construction equipment.

An apparatus for securing a cargo item within a cargo area that is defined by a pickup truck bed and a bed liner that is disposed within the pickup truck bed, the bed liner defining a plurality of elongate grooves. The apparatus includes a rod that extends along an axis in an axial direction of the rod. An engaging structure is receivable within at least one groove from the plurality of elongate grooves of the bed liner for engagement with the bed liner. An adjustable connecting structure connects the engaging structure to the rod and allows adjustment of an axial position of the engaging structure along the rod in the axial direction of the rod. A body is connected to the rod for engaging the cargo item.

An adjustable cargo storage press for organizing and securing cargo items stored in a cargo storage area of an automobile. The adjustable cargo storage press is disposed within or integrated with a cargo area of an automotive vehicle such as a trunk, bed or bed liner of a car, truck, or sport utility vehicle. The press prevents movement of cargo items and potential damage to the cargo items during transport. The press also maintains the position of the cargo items for easy removal from the cargo storage area. The press includes one or more hinged walls that lock in a vertical position and move towards each other along guide tracks. The one or more hinged walls compress the cargo items between the hinged walls, and fold flat when not in use so as not to limit cargo storage capacity of the cargo storage area.

An improved captive beam decking system is disclosed for use in a cargo trailer. The system includes a beam assembly and a foot assembly that is selectively engagable to a vertical sliding track system. The sliding track system is attached to the sidewall of a trailer vertically. The beam can be easily moved at different heights that are selected based upon the configuration of the cargo trailer.